The Delhi High Court has made a landmark ruling on pharmaceutical trademark infringement, protecting Sun Pharma's PANTOCID trademark and issuing an interim injunction. This ruling appears to be a significant development in the area of trademark law. The specifics of the case and the implications of the ruling are not clear from the available information.